Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2010 Jul 29.
Published in final edited form as: Tetrahedron Lett. 2009 Jul 29;50(30):4310–4313. doi: 10.1016/j.tetlet.2009.05.031

Efficient Organocatalytic α-Sulfenylation of Substituted Piperazine-2,5-diones

Ramin Dubey 1, Nathan W Polaske 1, Gary S Nichol 1, Bogdan Olenyuk 1,*
PMCID: PMC2699310  NIHMSID: NIHMS119708  PMID: 20161311

Abstract

Organocatalytic α-sulfenylation of substituted piperazine-2,5-diones is reported through the use of cinchona alkaloids as Lewis bases and electrophilic sulfur transfer reagents. 1-Phenylsulfanyl[1,2,4]triazole, a novel sulfur transfer reagent, gave excellent product yields with a number of substituted piperazine-2,5-diones under mild conditions. Catalyst loading, stoichiometry of sulfur electrophile, temperature and solvent were optimized to achieve high product yields.


Organocatalytic α-sulfenylation of carbonyl compounds is of considerable synthetic utility because it produces synthetic intermediates useful in a variety of organic transformations.1 To date, the majority of reported organocatalytic sulfenylations utilized aldehydes,2 ketones,3 lactones, lactams and β-dicarbonyl compounds4 as substrates. Despite their simplicity and low catalyst costs such transformations, to our knowledge, have not been reported for β-amido esters or diketopiperazines. In this communication, we report the first organocatalytic α-sulfenylation of substituted piperazine-2,5-diones.

Direct α-sulfenylation of substituted β-amido esters and diketopiperazines could facilitate synthesis of epidithiodiketopiperazines (ETPs) – an intriguing class of biologically active natural products.5 ETPs are cytotoxic and immunomodulatory constituents produced by the filamentous fungi Chaetomium and Pithomyces sp. They contain one or two polysulfide-bridged piperazine-2,5-dione fragments and display a broad spectrum of biological activity. Recent studies have shown that two members of this diverse family, chaetocin6 and chetomin7 (Figure 1), suppress neovascularization in solid tumors8 by disrupting the expression of VEGF gene mediated by hypoxia-inducible factor 1α (HIF-1α).9 All reported methods for the preparation of ETPs require multistep sequences for the introduction of sulfur.1013 Direct, catalytic procedure for α-sulfenylation of piperazine-2,5-diones could prove valuable in the development of a concise synthetic route to ETPs.

Figure 1.

Figure 1

Epidithiodiketopiperazine fungal metabolites.

Organocatalytic transformation of piperazine-2,5-dione ring system is more challenging as compared to aldehydes, ketones and esters due to its lower reactivity toward electrophilic sulfur reagents and greater steric bulk. Hence, the preliminary goal was to investigate the reactivity of the substituted piperazine-2,5-diones under typical conditions of organocatalytic α-sulfenylation with cinchona alkaloids as catalysts. Initially, 1-benzylsulfanyl[1,2,4]triazole (2a)2,4 was used as the electrophilic sulfenylating reagent in attempts to convert substrates 1a–1e to products 3 (Table 1). This reagent is known to give products in high yields with the variety of aldehydes, ketones and β-ketoesters.4 However, with substituted piperazine-2,5-dione 1a, only low yields of the product 3a were obtained. Therefore, our goal was to improve the efficiency of this reaction by varying the amount of sulfenylating reagent 2a and changing the type of catalyst 4a–4d (Figure 2).

Table 1.

Organocatalytic α-sulfenylation of 1a–1e with 1-benzylsulfanyl[1,2,4]triazole 2a and Lewis bases 4a–4d.

graphic file with name nihms119708f4.jpg
substrate solvent temp., °C time, hr catalyst eq. of 2a yield,a %
1a CH2Cl2 rt 120 4a 5.0 46
1a Toluene rt 120 4a 5.0 44
1a CH2Cl2 rt 120 4d 10.0 55
1b CH2Cl2 rt 48 4d 2.0 93
1b Toluene rt 24 4c 2.0 95
1b Toluene −10 24 4c 1.5 90
1b Toluene −78 24 4c 1.5 20
1b Toluene −10 24 4a 2.0 94
1b Toluene −10 24 4b 2.0 91
1cb Toluene rt 72 4a 2.6 10
1cb Toluene −10 72 4a 2.6 10
1db Toluene rt 72 4a 2.6 10
1e Toluene rt 72 4a 2.6 c
a

Yield of purified product after chromatographic separation.

b

3b was obtained as the product.

c

No product was formed, as observed by 1H NMR.

Figure 2.

Figure 2

Cinchona alkaloids used as catalysts.

In order to obtain higher yields, the loading of the sulfenylating reagent 2a was increased (Table 1). Despite using an excess of 2a, the product 3a was still obtained in low yields. Using precursor 1b without substituent at the N-4 position resulted in significantly improved yields. Compounds 1c and 1d gave product 3b in low yields, along with the removal of the substituents at the N-4 position. Such a removal could be the result of an attack of the formed in the trace amounts thiolate anion on acetyl or benzoyl groups of 1c–1d. The small quantities of the newly formed 1b could then be sulfenylated by 2a, producing compound 3b. No product formation could be observed with substrate 1e. It is believed that the low reactivity of the N-4 substituted piperazine-2,5-diones is attributable to the steric clash between the approaching sulfenylating reagent and the substrate, because only the compound lacking N-4 substituent, 1b, gave high yields with 2a. This limits the scope of 2a as an electrophile in sulfenylation of substituted piperazine-2,5-diones.

In an attempt to improve the substrate scope, we also synthesized 1-(p-methoxybenzyl)sulfanyl[1,2,4]triazole and 1-(p-nitrobenzyl)sulfanyl[1,2,4]triazole. These reagents, prepared in a manner similar to 2a, were found to be too unstable for practical application.

To improve yields, a new sulfenylating reagent 1-phenylsulfanyl[1,2,4]triazole (2b) was tested. This reagent gave excellent product yield with substrate 1a and was chosen for subsequent reaction optimizations. First, we screened the reaction conditions needed to efficiently carry out the αenylation with compound 2b. Catalysts, solvents, temperature as well as amounts of sulfenylating reagent 2b were varied in order to improve yields (Table 2). The most sterically bulky compound 1g was selected because its lower reactivity made it an ideal substrate for screening of sulfenylation conditions.

Table 2.

Optimization of reaction conditions of sulfenylation of 1g with 1-phenylsulfanyl[1,2,4]triazole 2b.

graphic file with name nihms119708f5.jpg
entry solvent temp, °C catalyst eq. of 2b yield,a %
1 CH2Cl2 rt 4c 2.0 79
2 Toluene rt 4a 2.0 60
3 Toluene rt 4b 2.0 65
4 Toluene rt 4c 2.0 91
6 Toluene 0 4c 3.0 97
5 PhH/PhMe (3:1) −10 4c 3.0 96
a

Yield of purified product after chromatographic separation.

Gratifyingly, sulfenylating reagent 2b gave considerably higher yields than 2a in all reactions with lower amounts of 2b required for efficient sulfenylation (Table 2). Different catalysts were screened, to find the most suitable candidate. The readily accessible quinine (4c) was found to be superior to catalysts (DHQD)2PYR (4a) and (DHQD)2PHAL (4b). This is probably due to the fact that the tertiary amines in both (DHQD)2PYR (4a) and (DHQD)2PHAL (4b) are more sterically demanding than quinine. Toluene and benzene/toluene mixture were also found to be superior to dichloromethane for obtaining high yields. The higher stability of 2b as compared to 2a under sulfenylation conditions has facilitated product isolation, because lesser amount of this reagent was required to obtain high yields.

Next, to test the substrate scope, the reactivity of 2b with other substituted piperazine-2,5-diones 1f–1j was studied. Compounds 1a and 1f gave excellent yields with 2b (Table 3). Substrates 1h and 1i with ethyl and benzyl groups at the N-4 position are more sterically demanding than substrates with a methyl group at that position. Compounds 1h and 1i were sulfenylated using 2b in high yields. This shows that 1-phenylsulfanyl[1,2,4]triazole (2b) is able to efficiently sulfenylate piperazine-2,5-dione substrates under different reaction conditions. Compound 1j which has a benzyl subtituent at the N-4 position and a t-butyl ester at the α-position, is the most sterically hindered substrate used in this study. It showed moderate yield with 2b and quinine 4c as the catalyst. When (DHQD)2PYR 4a and (DHQD)2PHAL 4b were used, no product formation was observed. Presumably the greater steric bulk of 4a and 4b played a major role in reducing the reaction rate when these catalysts were used with the bulky substrates. Because quinine is the least expensive organocatalyst among all tested cinchona alkaloids, its use in combination with the readily prepared 2b, provides an economical route to α-sulfenylated piperazine-2,5-diones.

Table 3.

Scope of α-sulfenylation of trisubstituted piperazine-2,5-diones with reagent 2b and 10 mol % of cinchona alkaloids 4a–4c.

graphic file with name nihms119708f6.jpg
entry substrate R1 R2 R3 solvent temp, °C catalyst eq. of 2b time, h product yield,a %
1 1f Me Me Me PhH/PhMe (3:1) −10 4c 3.0 18 3f 99
2 1a Me Me Et PhH/PhMe (3:1) −10 4c 3.0 30 3k 99
3 1g Me Me t-Bu PhH/PhMe (3:1) −10 4c 3.0 48 3g 96
4 1h Et Et Et Toluene rt 4c 3.0 60 3h 77
5 1h Et Et Et Toluene rt 4cb 8.0 48 3h 94
6 1i Bn Bn Et Toluene rt 4c 3.0 60 3i 75
7 1i Bn Bn Et Toluene rt 4cb 8.0 48 3i 95
8 1b H Me Et Toluene rt 4c 3.0 16 3l 81
9 1j Bn Bn t-Bu Toluene rt 4cb 10.0 72 3j 52
10 1j Bn Bn t-Bu Toluene rt 4a 2.0 60 3j 5
11 1j Bn Bn t-Bu Toluene rt 4b 2.0 60 3j 5
a

Yield of purified product after chromatographic separation.

b

20 mol% catalyst used.

Crystallization of product 3g from ethanol at room temperature provided single crystals suitable for X-ray diffraction analysis.14 The molecular structure of 3g is shown in Figure 3. The compound 3g has crystallized in the centrosymmetric orthorhombic space group Pbca and the crystal packing shows efficient stacking of the phenyl and diketopiperazine rings in the solid state. It is hypothesized that this stacking may provide additional stabilization in the transition state of the sulfenylation reaction.

Figure 3.

Figure 3

The molecular structure of 3g with anisotropic displacement parameters at 30% probability level.

In summary, direct and efficient organocatalytic α-sulfenylation of substituted piperazine-2,5-diones has been developed. Various substrates, solvents and sulfur transfer reagents have been screened, resulting in high product yields under optimized reaction conditions. This methodology may be of value for future construction of the epidithiodiketopiperazine ring system in a rapid and efficient manner. We continue structural modifications of electrophilic sulfur transfer reagents in order to expand their scope to sterically bulky substrates. Further exploration of the mechanism of organocatalytic α-sulfenylation and development of its enantioselective variant are currently under investigation.

Supplementary Material

01

Acknowledgments

Financial support of the University of Arizona is gratefully acknowledged. The X-ray diffractometer was purchased with support of the National Science Foundation (Grant CHE-9610374). We also thank the National Science Foundation (Grant CHE-0748838) and the National Institutes of Health (Grant R21 CA129388) for funding.

Footnotes

Supplementary Data

Synthetic procedures, characterization and NMR spectra of compounds 1 and 3 are available. Supplementary data associated with this article is available with its online version at doi:00.0000/j.tetlet.2009.00.0000.

Crystallographic data for 3g have been deposited into the Cambridge Crystallographic Data Centre (CCDC accession number 721744). These data can be obtained free of charge from www.ccdc.cam.ac.uk/data_request/cif.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.(a) Trost BM. Chem Rev. 1978;78:363–382. [Google Scholar]; (b) Trost BM. Acc Chem Res. 1978;11:453–461. [Google Scholar]
  • 2.Marigo M, Wabnitz TC, Fielenbach D, Jørgensen KA. Angew Chem, Int Ed. 2005;44:794–797. doi: 10.1002/anie.200462101. [DOI] [PubMed] [Google Scholar]
  • 3.Wang W, Li H, Wang J, Liao L. Tet Lett. 2004;45:8229–8231. [Google Scholar]
  • 4.Sobhani S, Fielenbach D, Marigo M, Wabnitz TC, Jørgensen KA. Chem Eur J. 2005;11:5689–5694. doi: 10.1002/chem.200500512. [DOI] [PubMed] [Google Scholar]
  • 5.(a) Saito T, Suzuki Y, Koyama K, Natori S, Iitaka Y, Kinoshita T. Chem Pharm Bull. 1988;36:1942–1956. [Google Scholar]; (b) Li GY, Li BG, Yang T, Yan JF, Liu GY, Zhang GL. J Nat Prod. 2006;69:1374–1376. doi: 10.1021/np0602970. [DOI] [PubMed] [Google Scholar]; (c) Fujimoto H, Sumino M, Okuyama E, Ishibashi M. J Nat Prod. 2004;67:98–102. doi: 10.1021/np0302201. [DOI] [PubMed] [Google Scholar]; (d) Gardiner DM, Waring P, Howlett BJ. Microbiology-(UK) 2005;151:1021–1032. doi: 10.1099/mic.0.27847-0. [DOI] [PubMed] [Google Scholar]
  • 6.Hauser D, Weber HP, Sigg HP. Helv Chim Acta. 1970;53:1061. doi: 10.1002/hlca.19700530521. [DOI] [PubMed] [Google Scholar]
  • 7.(a) Waksman SA, Bugie E. J Bacteriol. 1944;48:527–530. doi: 10.1128/jb.48.5.527-530.1944. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) McInnes AG, Taylor A, Walter JA. J Am Chem Soc. 1976;98:6741. doi: 10.1021/ja00437a074. [DOI] [PubMed] [Google Scholar]; (c) Brewer D, McInnes AG, Smith DG, Taylor A, Walter JA, Loosli HR, Kis ZL. J Chem Soc Perkin Trans. 1978;1:1248–1251. [Google Scholar]; (d) Fujimoto H, Sumino M, Okuyama E, Ishibashi M. J Nat Prod. 2004;67:98–102. doi: 10.1021/np0302201. [DOI] [PubMed] [Google Scholar]
  • 8.Kung AL, Zabludoff SD, France DS, Freedman SJ, Tanner EA, Vieira A, Cornell-Kennon S, Lee J, Wang B, Wang J, Memmert K, Naegeli HU, Petersen F, Eck MJ, Bair KW, Wood AW, Livingston DM. Cancer Cell. 2004;6:33–43. doi: 10.1016/j.ccr.2004.06.009. [DOI] [PubMed] [Google Scholar]
  • 9.Vaupel P, Thews O, Kelleher DK, Hoeckel M. Adv Exp Med Biol. 1998;454:591–602. doi: 10.1007/978-1-4615-4863-8_70. [DOI] [PubMed] [Google Scholar]
  • 10.(a) Williams RM, Rastetter WH. J Org Chem. 1980;45:2625–2631. [Google Scholar]; (b) Strunz GM, Kakushima M. Experientia. 1974;30:719–720. doi: 10.1007/BF01924146. [DOI] [PubMed] [Google Scholar]
  • 11.Fukuyama T, Nakatsuka S, Kishi Y. Tetrahedron. 1981;37:2045–2078. [Google Scholar]
  • 12.(a) Kishi Y, Nakatsuka S, Fukuyama T, Havel M. J Am Chem Soc. 1973;95:6493–6495. doi: 10.1021/ja00800a079. [DOI] [PubMed] [Google Scholar]; (b) Nakatsuka S, Fukuyama T, Kishi Y. Tetrahedron Lett. 1974:1549–1552. [Google Scholar]
  • 13.Overman LE, Sato T. Org Lett. 2007;9:5267–5270. doi: 10.1021/ol702518t. [DOI] [PubMed] [Google Scholar]
  • 14.Crystal data for 3g: C17H22N2O4S, 350.43 g.mol−1, colorless crystal 0.72 × 0.47 × 0.33 mm3, 220(2) K, Bruker SMART 1000 CCD diffractometer with a graphite monochromator (thin-slice ω scans, θ range from 2.2 to 27.1°), MoKα λ = 0.71073 Å, a = 11.4784(15) Å, b = 16.628(2) Å, c = 18.778(2) Å, V = 3584.1(8) Å3, Z = 8, ρcalc = 1.299 g.cm−3, μ = 0.203 mm−1, 2θmax = 27.1° 99.9% complete, reflections collected/unique = 28216/3954 (Rint = 0.0321), R1 = 0.0399, wR2 = 0.0928 for 2960 reflections with I > 2σ(I). See Supplementary data for complete X-ray crystallographic information.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01

RESOURCES